MNPR
Monopar Therapeutics·NASDAQ
--
--(--)
--
--(--)
MNPR Filings
Filing Date
Form Description
Form Type
2026-04-02
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-04-02 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-04-02
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-04-02 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-04-01
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Financials
2026-04-01 · Financials
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026-03-27
Form 8-K - Current report
Key Events
2026-03-27 · Key Events
Form 8-K - Current report
2026-03-27
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-27 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-04
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-04 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-04
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-04 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-03-02
Form 8-K - Current report
Key Events
2026-03-02 · Key Events
Form 8-K - Current report
2026-02-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-06
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-06 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
